LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Inicio・Lista de Acciones・MiNK Therapeutics

MiNK Therapeutics

Cerrado

10.81 -1.46

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

10.61

Máximo

10.81

Métricas clave
By Trading Economics
Ingresos	1.4M -2.9M
BPA	-0.65
Empleados	23
EBITDA	1.3M -2.8M

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-9.6M 53M
Apertura anterior	12.27
Cierre anterior	10.81

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

7.81 / 8.1 Soporte y Resistencia

MiNK Therapeutics Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 feb 2026, 23:53 UTC

Acciones populares

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

27 feb 2026, 22:23 UTC

Adquisiciones, fusiones, absorciones

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

28 feb 2026, 21:36 UTC

Ganancias

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb 2026, 15:20 UTC

Ganancias

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- 2nd Update

28 feb 2026, 14:43 UTC

Ganancias

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb 2026, 14:40 UTC

Noticias de Eventos Importantes

What Defense Stocks Stand to Gain -- and Lose -- From the U.S. Attacks on Iran -- Barrons.com

28 feb 2026, 14:38 UTC

Ganancias

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- Update

28 feb 2026, 13:51 UTC

Noticias de Eventos Importantes

What Defense Stocks Stand to Gain--and Lose--From the US Attacks on Iran -- Barrons.com

28 feb 2026, 13:47 UTC

Ganancias

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb 2026, 13:44 UTC

Ganancias

Berkshire Hathaway Earnings Slip on Decline in Insurance Results -- WSJ

28 feb 2026, 13:14 UTC

Ganancias

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb 2026, 12:41 UTC

Noticias de Eventos Importantes

Iran's Rulers Face an All-Out Battle for Survival -- Barrons.com

28 feb 2026, 10:30 UTC

Adquisiciones, fusiones, absorciones

All The Ways Netflix Actually Won Even Though It Lost Warner -- Heard on the Street -- WSJ

28 feb 2026, 02:32 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Calpers Buys Into Hot Chip And Quantum Stocks -- Barrons.com

28 feb 2026, 02:00 UTC

Adquisiciones, fusiones, absorciones

Six Months, 9 Offers and $81 Billion. How Hollywood's Nasty Takeover Was Won. -- WSJ

28 feb 2026, 02:00 UTC

Adquisiciones, fusiones, absorciones

Six Months, 9 Offers and $81 Billion. How -2-

28 feb 2026, 00:01 UTC

Adquisiciones, fusiones, absorciones

Paramount Issuing $47 Billion of Equity at Big Premium to Stock Price for Warner Bros. Deal -- Barrons.com

27 feb 2026, 23:46 UTC

Adquisiciones, fusiones, absorciones

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

27 feb 2026, 23:33 UTC

Adquisiciones, fusiones, absorciones

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

27 feb 2026, 21:50 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

27 feb 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

27 feb 2026, 21:30 UTC

Ganancias

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27 feb 2026, 21:30 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

27 feb 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

27 feb 2026, 21:17 UTC

Ganancias

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27 feb 2026, 21:10 UTC

Adquisiciones, fusiones, absorciones

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

27 feb 2026, 21:09 UTC

Adquisiciones, fusiones, absorciones

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

27 feb 2026, 21:00 UTC

Ganancias

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

27 feb 2026, 20:31 UTC

Adquisiciones, fusiones, absorciones

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

27 feb 2026, 20:24 UTC

Charlas de Mercado

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

Comparación entre iguales

Cambio de precio

MiNK Therapeutics previsión

Consenso

By TipRanks

0 ratings

Comprar

Mantener

Vender

De acuerdo con 0 analistas que ofrecen calificaciones bursátiles a para MiNK Therapeutics Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

7.81 / 8.1Soporte y Resistencia

Recent bullish events outweigh bearish events.

There is one bearish event.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Otras acciones del sector

LLY

Eli Lilly and Co.

1,050.93

↑ +2.96%

JNJ

Johnson and Johnson

248.43

↑ +2.06%

ABBV

AbbVie Inc

231.99

↑ +3.33%

NVS

Novartis AG

168.32

↑ +1.89%

MRK

Merck & Co Inc.

123.72

↑ +3.77%

MiNK Therapeutics

Resumen

Variación precio

Métricas clave

Estadísticas de Mercado

Puntuación técnica

MiNK Therapeutics Gráfico

Noticias Relacionadas

Comparación entre iguales

MiNK Therapeutics previsión

Consenso

Puntuación técnica

Finanzas

Otras acciones del sector